AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-α Production
- 15 January 2021
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 206 (2), 376-385
- https://doi.org/10.4049/jimmunol.2000953
Abstract
Several dinucleotide cyclases, including cyclic GMP–AMP synthase, and their involvement in STING-mediated immunity have been extensively studied. In this study, we tested five bacterial diguanylate cyclases from the Gram-negative bacterium Salmonella Enteritidis, identifying AdrA as the most potent inducer of a STING-mediated IFN response. AdrA wild-type (wt) or its inactive version AdrA mutant (mut) were delivered by an adenovirus (Ad) vector. Dendritic cells obtained from wt mice and infected in vitro with Ad vector containing AdrA wt, but not mut, had increased activation markers and produced large amounts of several immunostimulatory cytokines. For dendritic cells derived from STING-deficient mice, no activation was detected. The potential antiviral activity of AdrA was addressed in hepatitis B virus (HBV)-transgenic and adenovirus-associated virus (AAV)-HBV mouse models. Viremia in serum of Ad AdrA wt–treated mice was reduced significantly compared with that in Ad AdrA mut–injected mice. The viral load in the liver at sacrifice was in line with this finding. To further elucidate the molecular mechanism(s) by which AdrA confers its antiviral function, the response in mice deficient in STING or its downstream effector molecules was analyzed. wt and IFN-αR (IFNAR)−/− animals were additionally treated with anti–TNF-α (Enbrel). Interestingly, albeit less pronounced than in wt mice, in IFNAR−/− and Enbrel-treated wt mice, a reduction of serum viremia was achieved—an observation that was lost in anti–TNF-α–treated IFNAR−/− animals. No effect of AdrA wt was seen in STING-deficient animals. Thus, although STING is indispensable for the antiviral activity of AdrA, type I IFN and TNF-α are both required and act synergistically.Keywords
This publication has 57 references indexed in Scilit:
- Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune Response to Cyclic DinucleotidesPLOS ONE, 2013
- The prokaryote messenger c-di-GMP triggers stalk cell differentiation in DictyosteliumNature, 2012
- Sensing Adenovirus Infection: Activation of Interferon Regulatory Factor 3 in RAW 264.7 CellsJournal of Virology, 2012
- STING is a direct innate immune sensor of cyclic di-GMPNature, 2011
- A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene deliveryInternational Journal of Oncology, 2011
- TheN-Ethyl-N-Nitrosourea-InducedGoldenticketMouse Mutant Reveals an Essential Function ofStingin theIn VivoInterferon Response toListeria monocytogenesand Cyclic DinucleotidesInfection and Immunity, 2011
- Genetic reductionist approach for dissecting individual roles of GGDEF proteins within the c-di-GMP signaling network in SalmonellaProceedings of the National Academy of Sciences of the United States of America, 2009
- c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infectionVaccine, 2008
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature, 2008
- Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T LymphocytesImmunity, 1996